Treatment of patients with vertebrobasilar occlusive disease.
D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000209:etiology; D001488:Basilar Artery / Q000503:physiopathology; D002531:Cerebellum / Q000098:blood supply; D002544:Cerebral Infarction / Q000503:physiopathology; D004617:Embolism / Q000503:physiopathology; D005343:Fibrinolytic Agents; D006801:Humans; D008881:Migraine Disorders / Q000209:etiology; D013348:Subclavian Artery / Q000503:physiopathology; D014711:Vertebral Artery / Q000503:physiopathology; D014715:Vertebrobasilar Insufficiency / Q000188:drug therapy* / Q000209:etiology
D000925:Anticoagulants; D005343:Fibrinolytic Agents